Safety and efficacy of L-tryptophan and behavioral incentives for treatment of cocaine dependence: a randomized clinical trial.
Hendrée E Jones, Rolley E Johnson, George E Bigelow...
https://pubmed.ncbi.nlm.nih.gov/15764421Completed
Phase 2
Age: 18Years - 55Years
All Genders
ID00000324
Tryptophan and Behavior Therapy for Cocaine Abuse
Led by National Institute on Drug Abuse (NIDA) · Updated on 2017-01-12
200
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
N
National Institute on Drug Abuse (NIDA)
Lead Sponsor
J
Johns Hopkins University
Collaborating Sponsor
AI-Summary
What this Trial Is About
The purpose of this study is to assess the efficacy of tryptophan vs. placebo, and voucher payments vs. a control condition, in the treatment of cocaine dependence.
CONDITIONS
Official Title
Tryptophan and Behavior Therapy for Cocaine Abuse - 1
Who Can Participate
Age: 18Years - 55Years
All Genders
Eligibility Criteria
You may qualify if you...
- Cocaine dependent
You will not qualify if you...
- Physically dependent on drugs of abuse other than cocaine
- Significant medical or psychiatric illness (besides substance abuse disorder)
- Pregnant
Trial Site Locations
Total: 1 location
1
Johns Hopkins University School of Medicine
Baltimore, Maryland, United States, 21224
Status Unknown
Loading map...
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
N/A
Primary Purpose
TREATMENT
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here